Dental Management For Patients With Cardiovascular Disease: A Literature Review

Sidhi Laksono, Indira Khairunnisa Effendi

Abstract


The high prevalence of heart disease makes dentists often meet patients with this condition. Cardiac disorders commonly encountered in dental practice include hypertension, ischemic heart disease, cardiac arrhythmias, infective endocarditis, and arrhythmias. These patients required special consideration and adequate understanding of the cardiovascular conditions necessary to provide safe and effective dental care. Based on the heart condition, proper modification in dental care is very important. This article will discuss common heart conditions, how these diseases can affect dental care and prophylactic management and treatments that can be done to provide safe and optimal dental care.

Keywords


dental care; hypertension; ischemic heart disease; cardiac arrhythmias; anticoagulants

Full Text:

PDF

References


M. A. Al-Mohaissen, R. Al-Mehisen, T. Lee, and E. M. Al-Madi, “Managing Cardiac Patients: Dentists’ Knowledge, Perceptions, and Practices,” Int. Dent. J., vol. 72, no. 3, pp. 296–307, 2022, doi: https://doi.org/10.1016/j.identj.2021.04.006.

K. Gupta et al., “Dental Management Considerations for Patients with Cardiovascular Disease—A Narrative Review,” Rev. Cardiovasc. Med., vol. 23, no. 8, p. 261, Aug. 2022, doi: 10.31083/J.RCM2308261/2153-8174-23-8-261/FIG1.JPG.

B. Williams et al., “2018 ESC/ESH Guidelines for the management of arterial hypertensionThe Task Force for the management of arterial hypertension of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH),” Eur. Heart J., vol. 39, no. 33, pp. 3021–3104, Sep. 2018, doi: 10.1093/EURHEARTJ/EHY339.

B. Williams et al., “2018 ESC/ESH Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH),” Eur. Heart J., vol. 39, no. 33, pp. 3021–3104, 2018, doi: 10.1093/eurheartj/ehy339.

P. K. Whelton et al., “2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults a report of the American College of Cardiology/American Heart Association Task Force on Clinical practice guidelines,” Hypertension, vol. 71, no. 6, pp. E13–E115, Jun. 2018, doi: 10.1161/HYP.0000000000000065/-/DC2.

M. A. Rahman, H. R. Halder, U. N. Yadav, and S. K. Mistry, “Prevalence of and factors associated with hypertension according to JNC 7 and ACC/AHA 2017 guidelines in Bangladesh,” Sci. Reports 2021 111, vol. 11, no. 1, pp. 1–10, Jul. 2021, doi: 10.1038/s41598-021-94947-2.

M. Cruz-Pamplona, Y. Jimenez-Soriano, and M. Sarrion-Perez, “Dental considerations in patients with heart disease,” J. Clin. Exp. Dent., vol. 3, no. 2, pp. e97–e105, 2011, doi: 10.4317/jced.3.e97.

J. W. Little, “The impact on dentistry of recent advances in the management of hypertension.,” Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod., vol. 90, no. 5, pp. 591–9, Nov. 2000, doi: 10.1067/moe.2000.109517.

“The ADA Practical Guide to Patients with Medical Conditions - Lauren L. Patton - Google Books.” https://books.google.co.id/books?hl=en&lr=&id=XPnzBgAAQBAJ&oi=fnd&pg=PR5&dq=+Patton+LL,+Glick+M.+The+ADA+Practical+Guide+to+Patients+with+Medical+Conditions.+2nd+edn.+Wiley+&ots=9B18QkxQ19&sig=Wz8zZxk6ST6C0yXj2iBOBvsPIkg&redir_esc=y#v=onepage&q=Patton LL%25 (accessed Oct. 24, 2022).

M. Seminario-Amez, B. González-Navarro, R. Ayuso-Montero, E. Jané-Salas, and J. López-López, “USE OF LOCAL ANESTHETICS WITH A VASOCONSTRICTOR AGENT DURING DENTAL TREATMENT IN HYPERTENSIVE AND CORONARY DISEASE PATIENTS. A SYSTEMATIC REVIEW,” J. Evid. Based Dent. Pract., vol. 21, no. 2, p. 101569, Jun. 2021, doi: 10.1016/J.JEBDP.2021.101569.

C. Varounis, V. Katsi, P. Nihoyannopoulos, J. Lekakis, and D. Tousoulis, “Cardiovascular Hypertensive Crisis: Recent Evidence and Review of the Literature,” Front. Cardiovasc. Med., vol. 3, p. 51, Jan. 2016, doi: 10.3389/FCVM.2016.00051.

M. Margaix Muñoz, Y. Jiménez Soriano, R. Poveda Roda, and G. Sarrión, “Cardiovascular diseases in dental practice. Practical considerations.,” Med. Oral Patol. Oral Cir. Bucal, vol. 13, no. 5, pp. E296-302, May 2008.

N. I. Jowett and L. B. Cabot, “Patients with cardiac disease: considerations for the dental practitioner,” Br. Dent. J., vol. 189, no. 6, pp. 297–302, 2000, doi: 10.1038/sj.bdj.4800750.

S. Singh, K. Gupta, K. N. Garg, N. K. Fuloria, S. Fuloria, and T. Jain, “Dental Management of the Cardiovascular Compromised Patient: A Clinical Approach,” Dent. Manag. Cardiovasc. Compromised Patient A Clin. Approach, vol. 9, no. 4, pp. 453–456, Oct. 2017, doi: 10.5530/JYP.2017.9.89.

S. M. Lupi and A. R. Y. Baena, “Patients Taking Direct Oral Anticoagulants (DOAC) Undergoing Oral Surgery: A Review of the Literature and a Proposal of a Peri-Operative Management Protocol,” Healthcare, vol. 8, no. 3, 2020, doi: 10.3390/HEALTHCARE8030281.

C. M. Otto et al., “2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines,” J. Am. Coll. Cardiol., vol. 77, no. 4, pp. 450–500, Feb. 2021, doi: 10.1016/J.JACC.2020.11.035.

M. Sanz et al., “Periodontitis and cardiovascular diseases: Consensus report,” J. Clin. Periodontol., vol. 47, no. 3, p. 268, Mar. 2020, doi: 10.1111/JCPE.13189.

A. Vahanian et al., “Guidelines on the management of valvular heart disease: The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology,” Eur. Heart J., vol. 28, no. 2, pp. 230–268, 2007, doi: 10.1093/eurheartj/ehl428.

P. Pibarot and J. G. Dumesnil, “Prosthetic Heart Valves,” Circulation, vol. 119, no. 7, pp. 1034–1048, Feb. 2009, doi: 10.1161/CIRCULATIONAHA.108.778886.

M. Pototski and J. M. Amenábar, “Dental management of patients receiving anticoagulation or antiplatelet treatment,” J. Oral Sci., vol. 49, no. 4, pp. 253–258, 2007, doi: 10.2334/josnusd.49.253.

L. M. Baddour et al., “Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications,” Circulation, vol. 132, no. 15, pp. 1435–1486, 2015, doi: 10.1161/CIR.0000000000000296.

W. R. Wilson et al., “Prevention of Viridans Group Streptococcal Infective Endocarditis: A Scientific Statement From the American Heart Association,” Circulation, vol. 143, no. 20, pp. e963–e978, 2021, doi: 10.1161/CIR.0000000000000969.

F. Costantinides, R. Rizzo, L. Pascazio, and M. Maglione, “Managing patients taking novel oral anticoagulants (NOAs) in dentistry: a discussion paper on clinical implications,” BMC Oral Health, vol. 16, no. 1, Jan. 2016, doi: 10.1186/S12903-016-0170-7.




DOI: https://doi.org/10.31983/jkg.v10i1.9290

Article Metrics

Abstract view : 634
Download PDF : 1338

Refbacks

  • There are currently no refbacks.


Jurnal Kesehatan Gigi (p-ISSN: 2407-0866 e-ISSN: 2621-3664), is published by Jurusan Kesehatan Gigi, Politeknik Kesehatan Kemenkes Semarang, Jl. Tirto Agung, Pedalangan, Banyumanik, Semarang, Jawa Tengah, Indonesia, 50268 Telp./Fax: (024) 7471276.

Find us on : Instagram, Facebook

Abstracted/Indexed by:

 

 View My Stats